Kazuko Yonemori

521 total citations
11 papers, 285 citations indexed

About

Kazuko Yonemori is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Kazuko Yonemori has authored 11 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Organic Chemistry. Recurrent topics in Kazuko Yonemori's work include Advanced Breast Cancer Therapies (2 papers), Integrated Circuits and Semiconductor Failure Analysis (2 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). Kazuko Yonemori is often cited by papers focused on Advanced Breast Cancer Therapies (2 papers), Integrated Circuits and Semiconductor Failure Analysis (2 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). Kazuko Yonemori collaborates with scholars based in Japan and United States. Kazuko Yonemori's co-authors include Masahiro Kamaura, Tomoya Sameshima, Kotaro Sakamoto, Shigekazu Sasaki, Ayumu Niida, Masanori Miwa, Satoshi Sogabe, Junichi Sakamoto, Yusuke Kamada and Satoshi Yasuda and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Structure.

In The Last Decade

Kazuko Yonemori

10 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kazuko Yonemori Japan 9 193 80 37 33 30 11 285
Eliana MC Tacconi United Kingdom 6 345 1.8× 76 0.9× 51 1.4× 9 0.3× 28 0.9× 6 417
Sachio Shibata Japan 10 229 1.2× 41 0.5× 15 0.4× 11 0.3× 35 1.2× 14 312
Yumi Matsui Japan 13 242 1.3× 45 0.6× 32 0.9× 21 0.6× 59 2.0× 21 342
James R. Porter United States 8 350 1.8× 59 0.7× 59 1.6× 17 0.5× 28 0.9× 12 483
Matthew W. Martin United States 12 204 1.1× 84 1.1× 27 0.7× 7 0.2× 29 1.0× 19 338
Scott A. Long United States 9 212 1.1× 56 0.7× 38 1.0× 14 0.4× 15 0.5× 13 429
John M. Pritchard United Kingdom 11 191 1.0× 38 0.5× 102 2.8× 9 0.3× 20 0.7× 17 367
Zachariah H. Foda United States 7 275 1.4× 39 0.5× 39 1.1× 6 0.2× 61 2.0× 9 400
Jiacheng Wei China 8 269 1.4× 60 0.8× 88 2.4× 8 0.2× 8 0.3× 10 364
Christine Fernandes United States 9 278 1.4× 68 0.8× 35 0.9× 10 0.3× 26 0.9× 9 356

Countries citing papers authored by Kazuko Yonemori

Since Specialization
Citations

This map shows the geographic impact of Kazuko Yonemori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuko Yonemori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuko Yonemori more than expected).

Fields of papers citing papers by Kazuko Yonemori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuko Yonemori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuko Yonemori. The network helps show where Kazuko Yonemori may publish in the future.

Co-authorship network of co-authors of Kazuko Yonemori

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuko Yonemori. A scholar is included among the top collaborators of Kazuko Yonemori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuko Yonemori. Kazuko Yonemori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Carney, Daniel W., Michiko Tawada, Jumpei Aida, et al.. (2025). Discovery of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 Main Protease through Computer-Aided Drug Design. Journal of Medicinal Chemistry. 68(20). 21330–21345.
2.
Adachi, Naruhiko, Toshio Moriya, Hideyuki Oki, et al.. (2021). Cryo-EM Structure of K+-Bound hERG Channel Complexed with the Blocker Astemizole. Structure. 29(3). 203–212.e4. 59 indexed citations
3.
Matsumoto, Shin-ichi, et al.. (2017). Identification of PARP14 inhibitors using novel methods for detecting auto-ribosylation. Biochemical and Biophysical Research Communications. 486(3). 626–631. 21 indexed citations
4.
Fukase, Yoshiyuki, Atsuko Ochida, Kazuko Yonemori, et al.. (2017). Identification of novel quinazolinedione derivatives as RORγt inverse agonist. Bioorganic & Medicinal Chemistry. 26(3). 721–736. 17 indexed citations
5.
Ito, Masahiro, Michael G. Klein, Takeshi Yamamoto, et al.. (2017). Discovery of Allosteric Inhibitors Targeting the Spliceosomal RNA Helicase Brr2. Journal of Medicinal Chemistry. 60(13). 5759–5771. 28 indexed citations
6.
Tomita, Naoki, Youichi Kawakita, Y. ITO, et al.. (2017). Discovery of Novel and Potent Stearoyl Coenzyme A Desaturase 1 (SCD1) Inhibitors as Anticancer Agents. Bioorganic & Medicinal Chemistry. 25(14). 3768–3779. 28 indexed citations
7.
Fujimoto, Jun, Takaharu Hirayama, Yasuhiro Hirata, et al.. (2017). Studies of CDK 8/19 inhibitors: Discovery of novel and selective CDK8/19 dual inhibitors and elimination of their CYP3A4 time-dependent inhibition potential. Bioorganic & Medicinal Chemistry. 25(12). 3018–3033. 16 indexed citations
8.
Ono, Koji, Hiroshi Banno, Masanori Okaniwa, et al.. (2017). Design and synthesis of selective CDK8/19 dual inhibitors: Discovery of 4,5-dihydrothieno[3′,4′:3,4]benzo[1,2-d]isothiazole derivatives. Bioorganic & Medicinal Chemistry. 25(8). 2336–2350. 27 indexed citations
9.
Amano, Yuichiro, et al.. (2017). Farnesoid X receptor antagonist exacerbates dyslipidemia in mice. Pharmacological Reports. 70(1). 172–177. 5 indexed citations
10.
Niida, Ayumu, Shigekazu Sasaki, Kazuko Yonemori, et al.. (2017). Investigation of the structural requirements of K-Ras(G12D) selective inhibitory peptide KRpep-2d using alanine scans and cysteine bridging. Bioorganic & Medicinal Chemistry Letters. 27(12). 2757–2761. 29 indexed citations
11.
Sogabe, Satoshi, Yusuke Kamada, Masanori Miwa, et al.. (2017). Crystal Structure of a Human K-Ras G12D Mutant in Complex with GDP and the Cyclic Inhibitory Peptide KRpep-2d. ACS Medicinal Chemistry Letters. 8(7). 732–736. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eliana MC Tacconi Breakdown of academic impact, for papers by Sachio Shibata Breakdown of academic impact, for papers by Yumi Matsui Breakdown of academic impact, for papers by James R. Porter Breakdown of academic impact, for papers by Matthew W. Martin Breakdown of academic impact, for papers by Scott A. Long Breakdown of academic impact, for papers by John M. Pritchard Breakdown of academic impact, for papers by Zachariah H. Foda Breakdown of academic impact, for papers by Jiacheng Wei Breakdown of academic impact, for papers by Christine Fernandes
Rankless by CCL
2026